Cite
HARVARD Citation
Lightner, A. et al. (2019). Commonly Used Immunosuppressives Affect Mesenchymal Stem Cell Viability and Function: Should We Rethinking Clinical Trial Inclusion and Exclusion Criteria?. Crohn's & colitis 360. 1 (3), p. . [Online].